Indeed. It’s tough in this uncharted market to gauge overall valuation, especially when current earnings alone can’t be the sole indicator, but there is no way in hell based upon earnings, production capacity, geographic presence, and market share that ACB should have a market cap of less than half of CGC. CGC is still artificially inflated by the Constellation partnership. Not nearly as much as Cronos is incredibly overvalued due to the Altria infusion, but still. Based on this X factor, I predict an ACB large partner announcement would propel pps to roughly $14-15. Its just a matter of when, as ACB management plays very coy on the subject. I believe timing that announcement wrong could really kill a position though if you’re still taking profits on the small run ups and you get caught before a buying dip.
Market Data 
Markets 
